Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Surgeon Experience ReSTOR A +4 Intraocular Lens (IOL): Complete Statistical AnalysisIndependent statistical analysis of Surgeon Experience ReSTOR A +4 Intraocular Lens (IOL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00733512).
- Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix: Complete Statistical AnalysisIndependent statistical analysis of Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Surgical Pain After Inguinal Hernia Repair (SPAIHR): Complete Statistical AnalysisIndependent statistical analysis of Surgical Pain After Inguinal Hernia Repair (SPAIHR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00551135).
- Surgical Site Infection With 0.05% Chlorhexidine (CHG) Compared to Triple Antibiotic Irrigation: Complete Statistical AnalysisIndependent statistical analysis of Surgical Site Infection With 0.05% Chlorhexidine (CHG) Compared to Triple Antibiotic Irrigation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen: Complete Statistical AnalysisIndependent statistical analysis of Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand: Complete Statistical AnalysisIndependent statistical analysis of Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SURMOUNT-3Independent statistical analysis of A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SURMOUNT-CNIndependent statistical analysis of A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SURPASSIndependent statistical analysis of Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SURPASS-CVOTIndependent statistical analysis of A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SURPHIndependent statistical analysis of A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SURTAVIIndependent statistical analysis of Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).: primary…
- SURV1VEIndependent statistical analysis of SI + CC Versus 3:1 C:V Ratio During Neonatal CPR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02858583).
- SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Survey on Anemia Therapy in Participants With Chronic Kidney Disease (CKD) Not on Dialysis: Complete Statistical AnalysisIndependent statistical analysis of Survey on Anemia Therapy in Participants With Chronic Kidney Disease (CKD) Not on Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine: Complete Statistical AnalysisIndependent statistical analysis of Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SUSTAIN 10Independent statistical analysis of Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SUSTAIN™ 4Independent statistical analysis of Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes: primary…
- Suvorexant and Trauma Related Insomnia: Complete Statistical AnalysisIndependent statistical analysis of Suvorexant and Trauma Related Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02704754).
- SVRIIIIndependent statistical analysis of Long-term Outcomes of Children With Hypoplastic Left Heart Syndrome and the Impact of Norwood Shunt Type: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SWAP-ACIndependent statistical analysis of Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease: primary endpoint results, effect estimate with confidence interval,…
- SWAP3Independent statistical analysis of Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02016170).
- SWARM-PaIndependent statistical analysis of Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis: primary endpoint results, effect estimate with confidence…
- SWEDESIndependent statistical analysis of Comparison Between Thrombolysis and Primary Percutaneous Coronary Intervention (PCI) to Treat ST-Segment Elevation Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SweetDreams Sleep Study for Children With Autism: Complete Statistical AnalysisIndependent statistical analysis of SweetDreams Sleep Study for Children With Autism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04452045).
- SweetNalIndependent statistical analysis of Sweet Preference and Alcohol Craving: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01296646).
- SWIFTIndependent statistical analysis of Safety and Efficacy Study of Switching From Epzicom to Truvada: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00724711).
- SWIFTIndependent statistical analysis of SOLITAIRE™ FR With the Intention For Thrombectomy (SWIFT) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01054560).
- SWIFT-2Independent statistical analysis of A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SWIPEIndependent statistical analysis of Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SWITCHIndependent statistical analysis of Sleep Without Insomnia or The Use of Chronic Hypnotics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03687086).
- SWITCH 2Independent statistical analysis of A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes: primary endpoint results, effect estimate…
- SWITCH PROIndependent statistical analysis of A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study:…
- Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018): Complete Statistical AnalysisIndependent statistical analysis of Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA): Complete Statistical AnalysisIndependent statistical analysis of Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00796705).
- Sym004 in Patients With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Sym004 in Patients With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01117428).
- Symplicity AFIndependent statistical analysis of Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Symptom Screening Linked to Care Pathways: Complete Statistical AnalysisIndependent statistical analysis of Symptom Screening Linked to Care Pathways: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04614662).
- Symptomatic Relief of Acute Dyspeptic Pain in Emergency Department With Pantoprazole: Complete Statistical AnalysisIndependent statistical analysis of Symptomatic Relief of Acute Dyspeptic Pain in Emergency Department With Pantoprazole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00831233).
- Symptoms-StepsIndependent statistical analysis of In Person and mHealth Coping Skills Training for Symptom Management and Steps in Stem Cell Transplant Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Synagis RussiaIndependent statistical analysis of A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and…
- SynergyIndependent statistical analysis of ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04835441).
- SYNERGYIndependent statistical analysis of Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex: primary endpoint results, effect…
- SYSTANE® BALANCE Symptoms (OSDI) & Inflammatory Biomarkers: Complete Statistical AnalysisIndependent statistical analysis of SYSTANE® BALANCE Symptoms (OSDI) & Inflammatory Biomarkers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01733732).
- Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma: Complete Statistical AnalysisIndependent statistical analysis of Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents: Complete Statistical AnalysisIndependent statistical analysis of T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010: Complete Statistical AnalysisIndependent statistical analysis of T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…